$CBIO
Crescent Biopharma, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$16.95
▲+1.07%+$0.180
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateCrescent Biopharma, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is CBIO up today? It is at $16.95 (+0.00%), and our scanner flagged it 43 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CBIO spikes, and full due diligence on CBIO — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $CBIO 43 times in the last 30 days. Create a free account to track $CBIO, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on CBIO from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CBIO today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Fairmount Funds Management Llc Director | Bought (open market) | +853K 2.3% of company | added 31% | 3.60M | $12.4M at $14.50 | Jul 16, 26 |
Brumm Joshua T Officer | Sold (automatic/other) | -42K 0.1% of company | sold 13% | 281K | $761K at $17.99 | Jun 22, 26 |
Mcneill Jonathan Officer | Sold (automatic/other) | -21K 0.06% of company | sold 13% | 139K | $370K at $17.99 | Jun 22, 26 |
Im Ellie Eunkyung Officer | Sold (automatic/other) | -1K | sold 5.2% | 22K | $22K at $17.99 | Jun 22, 26 |
Bispham Barbara Harlin Officer | Sold (automatic/other) | -1K | sold 5.9% | 19K | $22K at $17.99 | Jun 22, 26 |
Scalzo Richard William Officer | Sold (automatic/other) | -1K | sold 5.2% | 20K | $20K at $17.99 | Jun 22, 26 |
Pinkas Jan Officer | Sold (automatic/other) | -1K | sold 5.5% | 22K | $23K at $17.99 | Jun 22, 26 |
Lynch Ryan Officer | Sold (automatic/other) | -465 | sold 3.2% | 14K | $8K at $17.99 | Jun 22, 26 |
Bispham Barbara Harlin Officer | Acquired (grant/award) | +18K 0.05% of company | n/a | 18K | n/a | Dec 15, 25 |
Lynch Ryan Officer | Acquired (grant/award) | +12K 0.03% of company | n/a | 12K | n/a | Dec 15, 25 |
Im Ellie Eunkyung Officer | Acquired (grant/award) | +21K 0.06% of company | n/a | 21K | n/a | Dec 15, 25 |
Mcneill Jonathan Officer | Acquired (grant/award) | +26K 0.07% of company | added 19% | 160K | n/a | Dec 15, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on CBIO from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CBIO today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
CBIO last traded at $16.95, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Crescent Biopharma, Inc. Common Stock (CBIO) is next expected to report earnings on Thursday, November 5, 2026, about 48 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The CBIO Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CBIO 43 times in the last 30 days.
CBIO (Crescent Biopharma, Inc. Common Stock) trades on XNAS, with a market cap of about $638M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CBIO for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CBIO discussion
Sign in to ask a question or join the discussion.